Sargaquinoic acid, which is derived from the brown alga S. sagamianum, exhibited moderate inhibitory activity against AChE (IC50 23.2 μM) but was particularly effective against BuChE, with an IC50 of 26 nM, positioning it as a promising candidate for the treatment of AD. This evidence concerns the gene ACHE and Alzheimer disease.